Medical Xpress
Language-based AI model spots early heart disease in ECGs, reaching 94.2% accuracy
Researchers have adapted Transformer architecture — the AI backbone behind large language models — to analyze ECGs and detect early-stage heart disease with 94.2% accuracy. The model proved effective across multiple established medical datasets, suggesting strong generalizability. As cardiovascular disease remains a leading cause of death worldwide, a reliable early-detection tool of this kind could significantly reduce diagnostic delays.
Read article →Guardian Health
Has a sick person you love gone down a medical conspiracy wormhole? Here’s what to do
When a loved one is seriously ill, the pull of alternative treatments and medical conspiracies can feel like hope — but it can also be deadly. One writer learned this firsthand after her cousin died following an unproven procedure sought abroad. Drawing on that loss, she explores how to compassionately intervene when someone you care about goes down a dangerous wellness rabbit hole.
Read article →Medical Xpress
Colorectal cancer research reveals new mechanism in targeted therapy against metastasis
Researchers at the Medical University of Vienna have discovered that EGFR — a primary target of existing colorectal cancer therapies — does more than act on cancer cells alone. The receptor also influences immune cells within the tumor microenvironment, shaping how effectively the body's own defenses can fight metastatic disease. The finding opens a new dimension in understanding targeted therapy and could inform more comprehensive treatment strategies.
Read article →Medical Xpress
Repurposed drugs move through late-stage trials at up to 90% lower cost
Universities and hospitals are running late-stage clinical trials on repurposed drugs at costs up to 90% below what pharmaceutical companies spend — a largely overlooked research pathway operating entirely outside the patent system. This shadow infrastructure is quietly delivering affordable treatments that commercial incentives would never prioritize. Scaling it up could fundamentally reshape how societies access medicines.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →